investing

This Health Care ETF Wins With More Exposure to Smaller Firms

Guggenheim S&P 500 Equal Weight Health Care approach to success is right there in its name.

Exchange-traded funds that focus on health care stocks tend to tilt toward the titans—companies such as Johnson & Johnson (symbol JNJ), Merck (MRK) and Pfizer (PFE). Those stocks have their merits. But the companies aren’t growing rapidly. For that, you’ll need to invest in smaller firms with more dynamic growth potential.

Guggenheim S&P 500 Equal Weight Health Care (RYH), a member of the Kiplinger ETF 20, doesn’t play favorites when it comes to a company’s size. As its name implies, the fund holds 62 stocks in equal proportions, each about 1.6% of the portfolio. Businesses such as Mettler-Toledo—a precision-instruments firm with a market value of $16.1 billion—carry as much weight in the ETF as J&J, valued at $349 billion. The mix, says Guggenheim, reduces bias toward the health care giants and provides more exposure to smaller firms with potentially superior stock returns.

Equally weighting stocks has been a winning strategy for the ETF. Mettler, for instance, has gained a total of 514% over the past decade—three times as much as big drug companies such as J&J (returns are as of September 29). Stocks such as Mettler have powered the ETF to an annualized return of 12.6% over the past 10 years, beating the 10.9% gain of the S&P 500 Health Care index (which weights stocks by market value). Impressively, the ETF has outperformed the index even though it has a somewhat steep expense ratio of 0.40%.

The ETF does have some drawbacks, one being meager dividends. Stocks in the fund yield an average of 0.9%, about half the health care industry average and well below what you can scoop up with a giant such as J&J (yielding 2.6%) or Pfizer (3.6%).

The ETF may also be a bit riskier than a health care fund secured by more weight in large companies. In 2016, the Guggenheim fund lost 4.5% (including dividends). That compares with a decline of 2.8% for the Health Care Select SPDR ETF (XLV), which ranks stocks by market cap and is tilted toward the heavyweights.

Overall, health care stocks look appealing. Many are benefiting from increased spending on insurance, medical devices and prescription drugs. That is helping a record proportion of companies beat analysts’ estimates for sales and profits. Yet the stocks as a group still look inexpensive, says Bank of America Merrill Lynch, which recommends the sector.

The big unknown, of course, is what to expect from the industry’s largest benefactor: Washington. Cuts in government spending on health care could lower revenues for hospitals, insurers and other firms. Analysts would then trim their sales and profit estimates, and the stocks could take a hit.

But even if Congress hits the brakes, spending growth would slow but not stop. The medical needs of an aging population will inevitably push up demand for health care, a trend that should make this ETF a long-term winner.

Most Popular

Will Your Stimulus Check Increase Your Tax on Social Security Benefits?
Coronavirus and Your Money

Will Your Stimulus Check Increase Your Tax on Social Security Benefits?

The answer to this question comes down to whether your stimulus check increases your "provisional income."
March 1, 2021
Where's My Refund? How to Track Your Tax Refund Status
tax refunds

Where's My Refund? How to Track Your Tax Refund Status

If you're waiting for your tax refund, the IRS has an online tool that lets you track the status of your payment.
March 2, 2021
4 Ways You May Be Sabotaging Your Career Success
careers

4 Ways You May Be Sabotaging Your Career Success

To be a success, it’s helpful to know what NOT to do on the job. An interview with the best-selling author of “The Art of Being Indispensable at Work”…
March 1, 2021

Recommended

The Social-Tracking BUZZ ETF: What It Is, What It Isn't
ETFs

The Social-Tracking BUZZ ETF: What It Is, What It Isn't

The VanEck Vectors Social Sentiment ETF (BUZZ) taps into social media's growing voice and David Portnoy's popularity. But the exposure it provides isn…
March 3, 2021
The 21 Best ETFs to Buy for a Prosperous 2021
Kiplinger's Investing Outlook

The 21 Best ETFs to Buy for a Prosperous 2021

Exposure to emerging trends. Core holdings. Tactical defensive plays. The 21 best ETFs for 2021 cover a wide range of options for numerous objectives.
March 1, 2021
T. Rowe Price Financial Services Banks on a Turnaround
Stock Market Today

T. Rowe Price Financial Services Banks on a Turnaround

This fund is a good way to bet on an economic rebound.
February 24, 2021
DSTL: A Value Fund With a Twist
Becoming an Investor

DSTL: A Value Fund With a Twist

The fund’s 51.3% return since its inception in 2018 has more than tripled that of traditional value funds.
February 24, 2021